Literature DB >> 18502063

Controlled release of donepezil intercalated in smectite clays.

Jin Kuen Park1, Young Bin Choy, Jae-Min Oh, Ju Young Kim, Seong-Ju Hwang, Jin-Ho Choy.   

Abstract

The inorganic-organic hybrid for a drug delivery system was successfully realized by intercalating donepezil molecules into smectite clays (laponite XLG, saponite, and montmorillonite). According to the powder XRD patterns, TG profiles, and FT-IR spectra, it was confirmed that donepezil molecules were well stabilized in the interlayer space of clay via mono or double layer stacking. The adsorption amount and molecular structure of donepezil appeared to depend on the cation exchange capacity of the clay, which in turn, tailored the drug release patterns. Especially in the presence of a bulky cationic polymer (Eudragit E-100) in the release media, the release rate was found to be improved due to its effective replacement with intercalated donepezil molecules. Therefore, to formulate a complete drug delivery system, the hybrids were coated with Eudragit E-100 using a spray dryer, which also showed great enhancement in the release rate during a short period of time (180min).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18502063     DOI: 10.1016/j.ijpharm.2008.04.012

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  16 in total

1.  Effect of dinitolmide intercalated into Montmorillonite on E. tenella infection in chickens.

Authors:  Daofeng Qu; Wenxiu Ma; Yongmeng Ye; Jianzhong Han
Journal:  Parasitol Res       Date:  2014-01-31       Impact factor: 2.289

2.  Clay enriched silk biomaterials for bone formation.

Authors:  Aneta J Mieszawska; Jabier Gallego Llamas; Christopher A Vaiana; Madhavi P Kadakia; Rajesh R Naik; David L Kaplan
Journal:  Acta Biomater       Date:  2011-04-22       Impact factor: 8.947

Review 3.  Laponite-Based Nanomaterials for Drug Delivery.

Authors:  Gita Kiaee; Nikolaos Dimitrakakis; Shabnam Sharifzadeh; Han-Jun Kim; Reginald K Avery; Kamyar Mollozadeh Moghaddam; Reihaneh Haghniaz; Ezgi Pinar Yalcintas; Natan Roberto de Barros; Solmaz Karamikamkar; Alberto Libanori; Ali Khademhosseini; Parastoo Khoshakhlagh
Journal:  Adv Healthc Mater       Date:  2022-02-04       Impact factor: 9.933

4.  Nanoparticle-reinforced associative network hydrogels.

Authors:  Sarvesh K Agrawal; Naomi Sanabria-Delong; Gregory N Tew; Surita R Bhatia
Journal:  Langmuir       Date:  2008-10-24       Impact factor: 3.882

5.  Montmorillonite-Alginate Composites as a Drug delivery System: Intercalation and In vitro Release of Diclofenac sodium.

Authors:  B D Kevadiya; H A Patel; G V Joshi; S H R Abdi; H C Bajaj
Journal:  Indian J Pharm Sci       Date:  2010-11       Impact factor: 0.975

6.  A nanohybrid system for taste masking of sildenafil.

Authors:  Ji-Hee Lee; Goeun Choi; Yeon-Ji Oh; Je Won Park; Young Bin Choy; Mung Chul Park; Yeo Joon Yoon; Hwa Jeong Lee; Hee Chul Chang; Jin-Ho Choy
Journal:  Int J Nanomedicine       Date:  2012-03-26

7.  Study on montmorillonite-chlorhexidine acetate-terbinafine hydrochloride intercalation composites as drug release systems.

Authors:  Baohong Sun; Ming Zhang; Ninglin Zhou; Xiaohong Chu; Ping Yuan; Cheng Chi; Fan Wu; Jian Shen
Journal:  RSC Adv       Date:  2018-06-12       Impact factor: 3.361

8.  Fluoromica nanoparticle cytotoxicity in macrophages decreases with size and extent of uptake.

Authors:  Nicolin Tee; Yingdong Zhu; Gysell M Mortimer; Darren J Martin; Rodney F Minchin
Journal:  Int J Nanomedicine       Date:  2015-03-26

9.  Hydrotalcite-Niclosamide Nanohybrid as Oral Formulation towards SARS-CoV-2 Viral Infections.

Authors:  Goeun Choi; Huiyan Piao; N Sanoj Rejinold; Seungjin Yu; Ki-Yeok Kim; Geun-Woo Jin; Jin-Ho Choy
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-19

10.  Factors affecting the design of slow release formulations of herbicides based on clay-surfactant systems. A methodological approach.

Authors:  María Del Carmen Galán-Jiménez; Yael-Golda Mishael; Shlomo Nir; Esmeralda Morillo; Tomás Undabeytia
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.